» Articles » PMID: 18573647

Relationship Between Pulmonary Function and Physical Activity in Daily Life in Patients with COPD

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2008 Jun 25
PMID 18573647
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It remains unclear how closely the physical inactivity observed in patients with Chronic Obstructive Pulmonary Disease (COPD) relates to the severity of their airflow limitation. Furthermore, it is unknown whether spirometric variables such as maximal voluntary ventilation (MVV) and inspiratory capacity (IC) reflect the level of physical activity in daily life better than the forced expiratory volume in the first second (FEV(1)), the main spirometric variable used to determine the severity of COPD. The objective of the present study was to investigate the relationship between physical activity in daily life and the severity of COPD assessed by different spirometric variables: MVV, IC and FEV(1).

Methods: Forty patients with COPD (21 men; 68+/-7 years; FEV(1) 41+/-14% predicted) were performed spirometry and assessment of the physical activity level in daily life using an accelerometer (SenseWear Armband).

Results: MVV was significantly correlated to total energy expenditure per day, energy expenditure per day in activities demanding more than 3 metabolic equivalents (METs), number of steps per day and time spent per day in moderate and vigorous activities (0.42<or=r<or=0.52; p<0.01 for all). Correlation of these variables with IC and especially FEV(1) was more modest, borderline or not statistically significant. There was no difference in time spent in vigorous activities among patients classified according to the FEV(1)-based GOLD stages II, III and IV, differently than that observed when patients were classified in groups according to their MVV.

Conclusion: In COPD patients, MVV better reflects the physical activity level in daily life than FEV(1) and IC.

Citing Articles

Determinants of Activity Phenotype in Patients with Chronic Obstructive Pulmonary Disease.

Murakami Y, Minakata Y, Kato M, Sasaki S, Azuma Y, Kawabe K Int J Chron Obstruct Pulmon Dis. 2023; 18:1919-1929.

PMID: 37671143 PMC: 10476663. DOI: 10.2147/COPD.S421755.


Utility of the Shortness of Breath in Daily Activities Questionnaire (SOBDA-Q) to Detect Sedentary Behavior in Patients with Chronic Obstructive Pulmonary Disease (COPD).

Yamaji Y, Hirano T, Ogawa H, Fukatsu-Chikumoto A, Matsuda K, Hamada K J Clin Med. 2023; 12(12).

PMID: 37373800 PMC: 10299225. DOI: 10.3390/jcm12124105.


The Role of Pulmonary Function Testing in the Diagnosis and Management of COPD.

Haynes J, Kaminsky D, Ruppel G Respir Care. 2023; 68(7):889-913.

PMID: 37353330 PMC: 10289615. DOI: 10.4187/respcare.10757.


An Overview of Human T-Lymphotropic Virus Type 1 Lung Injury.

Dias A, Falcao L, Quaresma J Front Immunol. 2022; 13:914498.

PMID: 35844492 PMC: 9285117. DOI: 10.3389/fimmu.2022.914498.


Computed tomography with 6-year follow-up demonstrates the evolution of HTLV-1 related lung injuries: A cohort study.

Dias A, Vieira W, Normando V, Franco K, Falcao A, de Sousa R PLoS One. 2021; 16(12):e0261864.

PMID: 34965281 PMC: 8716036. DOI: 10.1371/journal.pone.0261864.